ERCC1 and breast cancer: The increased risk of breast cancer under the allele model, heterozygous model and dominant model was still nominally significant (P=0.02, P=0.007, and P=0.01, respectively), which further confirmed the significant role played by ERCC1 rs11615 in breast cancer susceptibility.